Structural study by NMR of an oxorhenium-RGD decapeptide complex for application in radiotherapy |
| |
Authors: | Costopoulos Basil Benaki Dimitra Pelecanou Maria Mikros Emmanuel Stassinopoulou Chariklia I Varvarigou Alexandra D Archimandritis Spyridon C |
| |
Affiliation: | Institutes of Radioisotopes & Radiodiagnostic Products and Biology, National Centre for Scientific Research Demokritos, 153 10 Athens, Greece. |
| |
Abstract: | The decapeptide Arg-Gly-Asp-Ser-Cys-Arg-Gly-Asp-Ser-Tyr, which contains two Arg-Gly-Asp (RGD) moieties in its sequence, has been successfully labeled with radioactive rhenium (Re-188) yielding a single, stable oxorhenium complex. This complex is being evaluated for possible application in oncology as a target-specific radiotherapeutic agent, because its radioactive technetium-99m analogue has already been applied for the scintigraphic detection of malignant melanoma in humans. For structural characterization purposes, the complex of the decapeptide was synthesized at the macroscopic level using nonradioactive rhenium (Re-185/Re-187). NMR and mass spectral analysis of the nonradioactive oxorhenium complex revealed that the decapeptide coordinates to the oxorhenium core through the N(amide) of Asp3, the N(amide) of Ser4, and the N(amide) and S(thiolate) atoms of Cys5 to form a complex of the ReO[N(3)S] type. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|